Credit Suisse’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-977,426
| Closed | -$78M | – | 4748 |
|
|
2021
Q1 | $78M | Buy |
977,426
+74,778
| +8% | +$5.84M | 0.04% | 516 |
|
|
2020
Q4 | $71.2M | Buy |
902,648
+54,439
| +6% | +$3.19M | 0.03% | 550 |
|
|
2020
Q3 | $37.3M | Buy |
848,209
+93,671
| +12% | +$4.61M | 0.02% | 731 |
|
|
2020
Q2 | $33.4M | Buy |
754,538
+67,190
| +10% | +$2.51M | 0.02% | 708 |
|
|
2020
Q1 | $24.7M | Buy |
687,348
+166,798
| +32% | +$9.48M | 0.02% | 730 |
|
|
2019
Q4 | $36.9M | Buy |
520,550
+90,678
| +21% | +$6.58M | 0.03% | 710 |
|
|
2019
Q3 | $32.2M | Buy |
429,872
+16,078
| +4% | +$1.36M | 0.03% | 662 |
|
|
2019
Q2 | $33.4M | Buy |
413,794
+68,274
| +20% | +$4.8M | 0.03% | 639 |
|
|
2019
Q1 | $23.1M | Buy |
345,520
+35,336
| +11% | +$2.68M | 0.02% | 790 |
|
|
2018
Q4 | $23.1M | Sell |
310,184
-8,786
| -3% | -$725K | 0.02% | 721 |
|
|
2018
Q3 | $29.4M | Buy |
318,970
+75,442
| +31% | +$7.19M | 0.03% | 670 |
|
|
2018
Q2 | $24M | Buy |
243,528
+183,943
| +309% | +$20.6M | 0.02% | 746 |
|
|
2018
Q1 | $6.64M | Buy |
59,585
+19,262
| +48% | +$2.16M | 0.01% | 1521 |
|
|
2017
Q4 | $4.15M | Sell |
40,323
-18,201
| -31% | -$1.81M | ﹤0.01% | 1904 |
|
|
2017
Q3 | $5.51M | Sell |
58,524
-97,035
| -62% | -$7.66M | 0.01% | 1694 |
|
|
2017
Q2 | $12.1M | Sell |
155,559
-66,298
| -30% | -$4.98M | 0.01% | 1081 |
|
|
2017
Q1 | $17.8M | Sell |
221,857
-10,939
| -5% | -$869K | 0.02% | 888 |
|
|
2016
Q4 | $18.3M | Sell |
232,796
-16,593
| -7% | -$1.29M | 0.02% | 867 |
|
|
2016
Q3 | $19.4M | Buy |
249,389
+572
| +0.2% | +$41.5K | 0.02% | 836 |
|
|
2016
Q2 | $17.1M | Sell |
248,817
-44,600
| -15% | -$3.08M | 0.02% | 855 |
|
|
2016
Q1 | $20.9M | Buy |
293,417
+260,316
| +786% | +$16.3M | 0.03% | 703 |
|
|
2015
Q4 | $2.06M | Buy |
33,101
+6,270
| +23% | +$382K | ﹤0.01% | 2257 |
|
|
2015
Q3 | $1.52M | Buy |
26,831
+9,751
| +57% | +$516K | ﹤0.01% | 2471 |
|
|
2015
Q2 | $916K | Sell |
17,080
-3,966
| -19% | -$193K | ﹤0.01% | 3266 |
|
|
2015
Q1 | $1M | Sell |
21,046
-10,152
| -33% | -$449K | ﹤0.01% | 2975 |
|
|
2014
Q4 | $1.35M | Buy |
31,198
+18,653
| +149% | +$762K | ﹤0.01% | 2882 |
|
|
2014
Q3 | $432K | Sell |
12,545
-12,958
| -51% | -$458K | ﹤0.01% | 3736 |
|
|
2014
Q2 | $934K | Buy |
25,503
+11,701
| +85% | +$397K | ﹤0.01% | 3357 |
|
|
2014
Q1 | $465K | Sell |
13,802
-71,869
| -84% | -$2.37M | ﹤0.01% | 3766 |
|
|
2013
Q4 | $2.9M | Buy |
85,671
+66,817
| +354% | +$2.31M | ﹤0.01% | 2339 |
|
|
2013
Q3 | $602K | Buy |
18,854
+8,796
| +87% | +$234K | ﹤0.01% | 3381 |
|
|
2013
Q2 | $227K | Buy |
+10,058
| New | +$218K | ﹤0.01% | 3801 |
|
Credit Suisse's CMD Position: Q2 2021 in Review
Credit Suisse sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 977,426 shares — an estimated $78M sold.
Credit Suisse first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $78M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Credit Suisse reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Credit Suisse sold 977,426 Cantel Medical Corporation shares in Q2 2021, an estimated $78M.
- Credit Suisse first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Credit Suisse's Cantel Medical Corporation position peaked at $78M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.